Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 473 - Heterocyclic compounds containing purine ring systems
Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932)
01/2014
01/09/2014US20140011810 Compounds that Modulate EGFR Activity and Methods for Treating or Preventing Conditions Therewith
01/08/2014CN103497191A Method for separating and purifying adenine and 6-iso-xanthosine from trichosanthes kirilowii maxim peels
01/08/2014CN103044427B Refining and purification method of medical-grade adenine
01/08/2014CN102627643B Refining method for ganciclovir
01/08/2014CN102234280B D, L-guanosine analogs, preparation methods thereof and applications thereof
01/08/2014CN102105474B Purine PI3K inhibitor compounds and methods of use
01/07/2014US8623881 Inhibitors of human phosphatidylinositol 3-kinase delta
01/03/2014WO2014000673A1 Process for preparation of entecavir
01/02/2014US20140005208 Compositions useful for treating disorders related to trpa1
01/02/2014US20140005198 Raf kinase modulators and methods of use
01/02/2014US20140005193 Benzoimidazoles as prolyl hydroxylase inhibitors
01/02/2014US20140005164 Wnt pathway antagonists
12/2013
12/31/2013CA2742833C Pyridine and pyrimidine derivatives as phosphodiesterase 10 inhibitors
12/31/2013CA2567289C Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
12/27/2013WO2013191287A1 Alcohol oxidation catalyst and method for oxidizing alcohol using same
12/27/2013WO2013189237A1 Andrographolide analogue and application of andrographolide analogue to treatment
12/27/2013WO2013189219A1 Xanthine derivative
12/26/2013US20130345242 Heteroaryl compounds useful as inhibitors of e1 activating enzymes
12/26/2013US20130345216 Certain chemical entities, compositions and methods
12/26/2013US20130345192 Heterocyclic tyrosine kinase inhibitors
12/26/2013US20130344138 Methods of treatment for solid tumors
12/26/2013US20130344061 Treatment of lupus, fibrotic conditions, and inflammatory myopathies and other disorders using pi3 kinase inhibitors
12/25/2013CN103476767A Heterocyclic compounds as PI3 kinase inhibitors
12/25/2013CN103467590A Biological couplet, purine compounds for preparing biological couplet, synthetic method for preparing biological couplet, pharmaceutical preparation prepared from biological couplet and application of biological couplet in immune adjustment
12/25/2013CN103467469A Separation method of triacetyl ganciclovir isomer
12/25/2013CN103467468A Vidarabine and Vidarabine analogues synthesized by air oxidation hydrazine removal method
12/19/2013US20130338174 Purine derivatives
12/19/2013US20130338173 Carbocycle-Substituted Purine And 7-Deazapurine Compounds
12/19/2013US20130338094 Substituted pyrrolo]2,3-d]pyrimidines
12/18/2013EP2674417A2 Biaryl PDE4 inhibitors for treating inflammation
12/18/2013EP2673269A1 Heterocyclic compounds as pi3 kinase inhibitors
12/18/2013CN103450201A Preparation method of chiral 8-(3-aminopiperidine-1-yl)-xanthine
12/17/2013US8609860 Acid-labile trigger units
12/17/2013US8609833 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof
12/17/2013US8609656 Heteroarylphenylurea derivative
12/17/2013CA2733533C Hedgehog pathway modulators
12/12/2013WO2013184570A2 Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds
12/12/2013WO2013182993A1 Method for preparing nitrogen compounds
12/11/2013EP2672540A1 Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
12/11/2013CN103435615A Ganciclovir compound as well as preparation method and pharmaceutical composition thereof
12/11/2013CN103435614A Entecavir compound
12/10/2013USRE44638 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
12/10/2013US8604192 Cyclohexenyl nucleic acids analogs
12/10/2013US8604032 Chemical compounds, compositions and methods for kinase modulation
12/05/2013US20130324724 Methods for the synthesis of 1,3-substituted aminouracils and other xanthine-related compounds
12/05/2013US20130324564 Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3-7-dimethyl-1h-purine-2,6(3h,7h)-dione
12/05/2013US20130324562 Fused bicyclic heterocycles useful as dipeptidyl peptidase-iv inhibitors
12/05/2013US20130324561 Atropisomers of p13k-inhibiting compounds
12/04/2013EP2669377A2 Modified iRNA agents
11/2013
11/28/2013US20130317023 Novel purinylpyridinylamino-2,4-difluorophenyl sulfonamide derivative, pharmaceutically acceptable salt thereof, preparation method thereof, and pharmaceutical composition with inhibitory activity against raf kinase, containing same as active ingredient
11/28/2013US20130315862 Methods and compositions for treating hepatitis c virus
11/27/2013EP2666858A1 Modified iRNA agents
11/27/2013CN103408548A Method for synthesizing (R)-9-(2-hydroxy propyl) adenine
11/27/2013CN103408547A Preparation method of tenofovir intermediate (R)-1-(6-aminopurine-9-yl)-2-propanol (I)
11/27/2013CN103408546A 2-phenylaminopurine PLK1 (Polo-like kinase 1) inhibitors and applications thereof
11/26/2013US8592581 Trisubstituted purine derivatives
11/26/2013US8592433 Compounds and compositions as protein kinase inhibitors
11/21/2013WO2013171756A1 Amorphous form of linagliptin and process for preparation thereof
11/21/2013US20130310404 Inhibitors of p75 receptor and their uses
11/21/2013US20130310403 Fluoro-homoneplanocin A and nucleoside derivatives, method for the synthesis thereof, and the pharmaceutical compositions comprising the same as an active component for treatment of cancer
11/21/2013US20130310347 Multi-modality molecular imaging high-throughput assay for identifying heat shock protein 90 (hsp90) inhibitors
11/21/2013US20130310345 Use of TRPA1 Antagonists to Prevent or Treat Infections Caused by Biological-Warfare Agents
11/20/2013EP2664672A1 Modified iRNA agents
11/20/2013EP2664619A1 Purine derivatives as tools for screening anti-Alzheimer compounds
11/20/2013EP2664617A1 Method of making a 2,6-diaryl piperidine derivative
11/20/2013EP2663309A1 Processes for preparing isoquinolinones and solid forms of isoquinolinones
11/20/2013EP2112151B1 Haloaryl substituted aminopurines for use in treatment
11/20/2013EP1613628B1 Reversible inhibitors of s-adenosyl-l-homocysteine hydrolase and uses thereof
11/19/2013US8586739 Heterocyclic compounds and their uses
11/19/2013US8586738 Process for the preparation of valganciclovir hydrochloride
11/19/2013US8586597 6-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)ethyl]-3H-quinazolin-4-one as an inhibitor of human phosphatidylinositol 3-kinase delta
11/19/2013US8586566 Unsaturated heterocyclic derivatives
11/14/2013WO2013168015A1 Compositions and methods for the treatment of asthma and allergy
11/14/2013WO2013167992A1 Compositions and methods for the treatment of inflammatory disorders
11/14/2013US20130303761 Compounds as modulators of a mutant cftr protein and their use for treating diseases associated with cftr protein malfunction
11/14/2013US20130303554 Use of a dpp-4 inhibitor in sirs and/or sepsis
11/14/2013US20130303553 Fused heterocyclic compounds
11/14/2013US20130303529 Fused heterocyclic derivatives and methods of use
11/14/2013US20130303521 Compounds and compositions for treating chemical warfare agent-induced injuries
11/14/2013US20130303491 Antiviral Drugs for Treatement or Prevention of Dengue Infection
11/14/2013US20130303462 Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
11/13/2013CN103387576A Aramide Raf kinase inhibitor based on purine structure and preparation method and application thereof
11/13/2013CN101671336B Aromatic heterocyclic pyridine derivatives and analogs and preparation method and application thereof
11/12/2013USRE44599 Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
11/12/2013CA2747777C A method for preparing entecavir and intermediates thereof
11/07/2013WO2013166110A1 Tlr-agonist-conjugated antibody recruiting molecules (tlr_arms)
11/07/2013US20130296558 Preparation process of an antiviral drug (entecavir) and intermediates thereof
11/07/2013US20130296346 Diphenyl-amine derivatives: uses, process of synthesis and pharmaceutical compositions
11/07/2013US20130296333 Hedgehog pathway modulators
11/06/2013EP2660322A2 Modified iRNA agents
11/06/2013CN101801970B Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient
11/06/2013CN101448822B Substituted pyrazolopyrimidines
11/05/2013US8575340 Purine derivatives and their pharmaceutical uses
11/05/2013US8575182 6, 9-disubstituted purine derivatives and their use as cosmetics and cosmetic compositions
11/05/2013US8575181 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
11/05/2013US8575180 9-substituted 8-oxoadenine compound
10/2013
10/31/2013WO2013161904A1 Sulfonamide derivative and medicinal use thereof
10/31/2013WO2013128379A3 Crystalline polymorphic forms of linagliptin
10/31/2013US20130289037 Inhibitors of e1 activting enzymes
10/31/2013US20130289015 N-containing heteroaryl derivatives as jak3 kinase inhibitors
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 ... 120